BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Parlesak A, Schäfer C, Schütz T, Bode JC, Bode C. Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease. J Hepatol. 2000;32:742-747. [PMID: 10845660 DOI: 10.1016/s0168-8278(00)80242-1] [Cited by in Crossref: 399] [Cited by in F6Publishing: 209] [Article Influence: 18.1] [Reference Citation Analysis]
Number Citing Articles
1 Malazogu F, Rousseau RK, Shivappa N, Huibner S, Walmsley SL, Kovacs CM, Benko E, Reinhard RJ, Rosenes R, Hebert JR, Kaul R. The Dietary Inflammatory Index Is Not Associated With Gut Permeability or Biomarkers of Systemic Inflammation in HIV Immunologic Non-responders. Front Nutr 2021;8:736816. [PMID: 34881278 DOI: 10.3389/fnut.2021.736816] [Reference Citation Analysis]
2 Leclercq S, Matamoros S, Cani PD, Neyrinck AM, Jamar F, Stärkel P, Windey K, Tremaroli V, Bäckhed F, Verbeke K, de Timary P, Delzenne NM. Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc Natl Acad Sci U S A 2014;111:E4485-93. [PMID: 25288760 DOI: 10.1073/pnas.1415174111] [Cited by in Crossref: 377] [Cited by in F6Publishing: 365] [Article Influence: 47.1] [Reference Citation Analysis]
3 Yue R, Wei X, Zhao J, Zhou Z, Zhong W. Essential Role of IFN-γ in Regulating Gut Antimicrobial Peptides and Microbiota to Protect Against Alcohol-Induced Bacterial Translocation and Hepatic Inflammation in Mice. Front Physiol 2020;11:629141. [PMID: 33536944 DOI: 10.3389/fphys.2020.629141] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Hartmann P, Hochrath K, Horvath A, Chen P, Seebauer CT, Llorente C, Wang L, Alnouti Y, Fouts DE, Stärkel P, Loomba R, Coulter S, Liddle C, Yu RT, Ling L, Rossi SJ, DePaoli AM, Downes M, Evans RM, Brenner DA, Schnabl B. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice. Hepatology 2018;67:2150-66. [PMID: 29159825 DOI: 10.1002/hep.29676] [Cited by in Crossref: 99] [Cited by in F6Publishing: 98] [Article Influence: 24.8] [Reference Citation Analysis]
5 Louvet A, Mathurin P. Alcoholic liver disease: mechanisms of injury and targeted treatment. Nat Rev Gastroenterol Hepatol. 2015;12:231-242. [PMID: 25782093 DOI: 10.1038/nrgastro.2015.35] [Cited by in Crossref: 371] [Cited by in F6Publishing: 343] [Article Influence: 53.0] [Reference Citation Analysis]
6 Forsyth CB, Farhadi A, Jakate SM, Tang Y, Shaikh M, Keshavarzian A. Lactobacillus GG treatment ameliorates alcohol-induced intestinal oxidative stress, gut leakiness, and liver injury in a rat model of alcoholic steatohepatitis. Alcohol 2009;43:163-72. [PMID: 19251117 DOI: 10.1016/j.alcohol.2008.12.009] [Cited by in Crossref: 229] [Cited by in F6Publishing: 216] [Article Influence: 17.6] [Reference Citation Analysis]
7 Kalaitzakis E. Gastrointestinal dysfunction in liver cirrhosis. World J Gastroenterol 2014; 20(40): 14686-14695 [PMID: 25356031 DOI: 10.3748/wjg.v20.i40.14686] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 48] [Article Influence: 6.5] [Reference Citation Analysis]
8 Wang W, Li Q, Chai W, Sun C, Zhang T, Zhao C, Yuan Y, Wang X, Liu H, Ye H. Lactobacillus paracasei Jlus66 extenuate oxidative stress and inflammation via regulation of intestinal flora in rats with non alcoholic fatty liver disease. Food Sci Nutr 2019;7:2636-46. [PMID: 31428351 DOI: 10.1002/fsn3.1118] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
9 Delcò F, Tchambaz L, Schlienger R, Drewe J, Krähenbühl S. Dose adjustment in patients with liver disease. Drug Saf 2005;28:529-45. [PMID: 15924505 DOI: 10.2165/00002018-200528060-00005] [Cited by in Crossref: 144] [Cited by in F6Publishing: 103] [Article Influence: 9.0] [Reference Citation Analysis]
10 Tong J, Wang Y, Chang B, Zhang D, Liu P, Wang B. Activation of RhoA in alcohol-induced intestinal barrier dysfunction. Inflammation 2013;36:750-8. [PMID: 23361851 DOI: 10.1007/s10753-013-9601-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
11 Leclercq S, de Timary P, Delzenne NM, Stärkel P. The link between inflammation, bugs, the intestine and the brain in alcohol dependence. Transl Psychiatry 2017;7:e1048. [PMID: 28244981 DOI: 10.1038/tp.2017.15] [Cited by in Crossref: 76] [Cited by in F6Publishing: 72] [Article Influence: 15.2] [Reference Citation Analysis]
12 DuPont AW, DuPont HL. The intestinal microbiota and chronic disorders of the gut. Nat Rev Gastroenterol Hepatol. 2011;8:523-531. [PMID: 21844910 DOI: 10.1038/nrgastro.2011.133] [Cited by in Crossref: 204] [Cited by in F6Publishing: 189] [Article Influence: 18.5] [Reference Citation Analysis]
13 Fulham MA, Mandrekar P. Sexual Dimorphism in Alcohol Induced Adipose Inflammation Relates to Liver Injury. PLoS One 2016;11:e0164225. [PMID: 27711160 DOI: 10.1371/journal.pone.0164225] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 4.3] [Reference Citation Analysis]
14 Seo YS, Shah VH. The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol 2012;18:337-46. [PMID: 23323248 DOI: 10.3350/cmh.2012.18.4.337] [Cited by in Crossref: 80] [Cited by in F6Publishing: 79] [Article Influence: 8.0] [Reference Citation Analysis]
15 Ceccarelli S, Nobili V, Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J Gastroenterol. 2014;20:16443-16451. [PMID: 25469012 DOI: 0.3748/wjg.v20.i44.16443] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Betrapally NS, Gillevet PM, Bajaj JS. Gut microbiome and liver disease. Transl Res. 2017;179:49-59. [PMID: 27477080 DOI: 10.1016/j.trsl.2016.07.005] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 7.2] [Reference Citation Analysis]
17 Deng YD, Peng XB, Zhao RR, Ma CQ, Li JN, Yao LQ. The intestinal microbial community dissimilarity in hepatitis B virus-related liver cirrhosis patients with and without at alcohol consumption. Gut Pathog. 2019;11:58. [PMID: 31788031 DOI: 10.1186/s13099-019-0337-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
18 Fukui H. Role of Gut Dysbiosis in Liver Diseases: What Have We Learned So Far? Diseases. 2019;7. [PMID: 31726747 DOI: 10.3390/diseases7040058] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 10.3] [Reference Citation Analysis]
19 Jung F, Burger K, Staltner R, Brandt A, Mueller S, Bergheim I. Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease. Nutrients 2021;13:1659. [PMID: 34068838 DOI: 10.3390/nu13051659] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Jeong WI, Gao B. Innate immunity and alcoholic liver fibrosis. J Gastroenterol Hepatol. 2008;23 Suppl 1:S112-S118. [PMID: 18336653 DOI: 10.1111/j.1440-1746.2007.05274.x] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
21 Portincasa P, Bonfrate L, Khalil M, Angelis MD, Calabrese FM, D’amato M, Wang DQ, Di Ciaula A. Intestinal Barrier and Permeability in Health, Obesity and NAFLD. Biomedicines 2022;10:83. [DOI: 10.3390/biomedicines10010083] [Reference Citation Analysis]
22 Forsyth CB, Voigt RM, Burgess HJ, Swanson GR, Keshavarzian A. Circadian rhythms, alcohol and gut interactions. Alcohol. 2015;49:389-398. [PMID: 25499101 DOI: 10.1016/j.alcohol.2014.07.021] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 4.1] [Reference Citation Analysis]
23 Zhou Z, Zhong W. Targeting the gut barrier for the treatment of alcoholic liver disease. Liver Res 2017;1:197-207. [PMID: 30034913 DOI: 10.1016/j.livres.2017.12.004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
24 Mencin A, Kluwe J, Schwabe RF. Toll-like receptors as targets in chronic liver diseases. Gut. 2009;58:704-720. [PMID: 19359436 DOI: 10.1136/gut.2008.156307] [Cited by in Crossref: 225] [Cited by in F6Publishing: 226] [Article Influence: 17.3] [Reference Citation Analysis]
25 Yan AW, Fouts DE, Brandl J, Stärkel P, Torralba M, Schott E, Tsukamoto H, Nelson KE, Brenner DA, Schnabl B. Enteric dysbiosis associated with a mouse model of alcoholic liver disease. Hepatology 2011;53:96-105. [PMID: 21254165 DOI: 10.1002/hep.24018] [Cited by in Crossref: 410] [Cited by in F6Publishing: 410] [Article Influence: 34.2] [Reference Citation Analysis]
26 Fukui H. Gut-liver axis in liver cirrhosis: How to manage leaky gut and endotoxemia. World J Hepatol 2015; 7(3): 425-442 [PMID: 25848468 DOI: 10.4254/wjh.v7.i3.425] [Cited by in Crossref: 99] [Cited by in F6Publishing: 87] [Article Influence: 14.1] [Reference Citation Analysis]
27 Mu Q, Kirby J, Reilly CM, Luo XM. Leaky Gut As a Danger Signal for Autoimmune Diseases. Front Immunol. 2017;8:598. [PMID: 28588585 DOI: 10.3389/fimmu.2017.00598] [Cited by in Crossref: 178] [Cited by in F6Publishing: 150] [Article Influence: 35.6] [Reference Citation Analysis]
28 Jin X, Yu CH, Lv GC, Li YM. Increased intestinal permeability in pathogenesis and progress of nonalcoholic steatohepatitis in rats. World J Gastroenterol 2007; 13(11): 1732-1736 [PMID: 17461479 DOI: 10.3748/wjg.v13.i11.1732] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
29 Ciocan D, Rebours V, Voican CS, Wrzosek L, Puchois V, Cassard AM, Perlemuter G. Characterization of intestinal microbiota in alcoholic patients with and without alcoholic hepatitis or chronic alcoholic pancreatitis. Sci Rep 2018;8:4822. [PMID: 29555983 DOI: 10.1038/s41598-018-23146-3] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 8.8] [Reference Citation Analysis]
30 Zhong W, Li Q, Xie G, Sun X, Tan X, Sun X, Jia W, Zhou Z. Dietary fat sources differentially modulate intestinal barrier and hepatic inflammation in alcohol-induced liver injury in rats. Am J Physiol Gastrointest Liver Physiol. 2013;305:G919-G932. [PMID: 24113767 DOI: 10.1152/ajpgi.00226.2013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 4.0] [Reference Citation Analysis]
31 Suraweera DB, Weeratunga AN, Hu RW, Pandol SJ, Hu R. Alcoholic hepatitis: The pivotal role of Kupffer cells. World J Gastrointest Pathophysiol 2015; 6(4): 90-98 [PMID: 26600966 DOI: 10.4291/wjgp.v6.i4.90] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
32 Luo L, Liu Y, Cai X, Wang Y, Xue J, Zhang J, Yang F. Bletilla striata polysaccharides ameliorates lipopolysaccharide-induced injury in intestinal epithelial cells. Saudi J Gastroenterol 2019;25:302-8. [PMID: 31044747 DOI: 10.4103/sjg.SJG_520_18] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
33 Li X, Hammer AM, Rendon JL, Choudhry MA. Intestine immune homeostasis after alcohol and burn injury. Shock 2015;43:540-8. [PMID: 25692258 DOI: 10.1097/SHK.0000000000000353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
34 Wan SZ, Liu C, Huang CK, Luo FY, Zhu X. Ursolic Acid Improves Intestinal Damage and Bacterial Dysbiosis in Liver Fibrosis Mice. Front Pharmacol 2019;10:1321. [PMID: 31736766 DOI: 10.3389/fphar.2019.01321] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
35 Vonlaufen A, Spahr L, Apte MV, Frossard JL. Alcoholic pancreatitis: A tale of spirits and bacteria. World J Gastrointest Pathophysiol 2014; 5(2): 82-90 [PMID: 24891979 DOI: 10.4291/wjgp.v5.i2.82] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
36 Dunn W, Shah VH. Pathogenesis of Alcoholic Liver Disease. Clin Liver Dis. 2016;20:445-456. [PMID: 27373608 DOI: 10.1016/j.cld.2016.02.004] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 9.8] [Reference Citation Analysis]
37 Zeng T, Zhang CL, Xiao M, Yang R, Xie KQ. Critical Roles of Kupffer Cells in the Pathogenesis of Alcoholic Liver Disease: From Basic Science to Clinical Trials. Front Immunol 2016;7:538. [PMID: 27965666 DOI: 10.3389/fimmu.2016.00538] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
38 Shim YR, Jeong WI. Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease. Exp Mol Med 2020;52:772-80. [PMID: 32457490 DOI: 10.1038/s12276-020-0438-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
39 Camilleri M, Vella A. What to do about the leaky gut. Gut 2021:gutjnl-2021-325428. [PMID: 34509978 DOI: 10.1136/gutjnl-2021-325428] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Bruneau A, Hundertmark J, Guillot A, Tacke F. Molecular and Cellular Mediators of the Gut-Liver Axis in the Progression of Liver Diseases. Front Med (Lausanne) 2021;8:725390. [PMID: 34650994 DOI: 10.3389/fmed.2021.725390] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
41 Alisi A, Carpino G, Oliveira FL, Panera N, Nobili V, Gaudio E. The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications. Mediators Inflamm. 2017;2017:8162421. [PMID: 28115795 DOI: 10.1155/2017/8162421] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 14.4] [Reference Citation Analysis]
42 Amaral GP, Dobrachinski F, de Carvalho NR, Barcelos RP, da Silva MH, Lugokenski TH, Dias GRM, de Lima Portella R, Fachinetto R, Soares FAA. Multiple mechanistic action of Rosmarinus officinalis L. extract against ethanol effects in an acute model of intestinal damage. Biomedicine & Pharmacotherapy 2018;98:454-9. [DOI: 10.1016/j.biopha.2017.12.091] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Hartmann P, Schnabl B. New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease. Semin Liver Dis 2021;41:87-102. [PMID: 33957682 DOI: 10.1055/s-0040-1719174] [Reference Citation Analysis]
44 Punzalan CS, Bukong TN, Szabo G. Alcoholic hepatitis and HCV interactions in the modulation of liver disease. J Viral Hepat. 2015;22:769-776. [PMID: 25754333 DOI: 10.1111/jvh.12399] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
45 Purohit V, Bode JC, Bode C, Brenner DA, Choudhry MA, Hamilton F, Kang YJ, Keshavarzian A, Rao R, Sartor RB, Swanson C, Turner JR. Alcohol, intestinal bacterial growth, intestinal permeability to endotoxin, and medical consequences: summary of a symposium. Alcohol 2008;42:349-61. [PMID: 18504085 DOI: 10.1016/j.alcohol.2008.03.131] [Cited by in Crossref: 198] [Cited by in F6Publishing: 185] [Article Influence: 14.1] [Reference Citation Analysis]
46 Cespiati A, Meroni M, Lombardi R, Oberti G, Dongiovanni P, Fracanzani AL. Impact of Sarcopenia and Myosteatosis in Non-Cirrhotic Stages of Liver Diseases: Similarities and Differences across Aetiologies and Possible Therapeutic Strategies. Biomedicines 2022;10:182. [DOI: 10.3390/biomedicines10010182] [Reference Citation Analysis]
47 Gadour E, Mohamed T, Hassan Z, Hassan A. Meta-Analysis and Systematic Review of Primary Renal Tubular Acidosis in Patients With Autoimmune Hepatitis and Alcoholic Hepatitis. Cureus 2021;13:e15287. [PMID: 34079685 DOI: 10.7759/cureus.15287] [Reference Citation Analysis]
48 Arab JP, Martin-Mateos RM, Shah VH. Gut-liver axis, cirrhosis and portal hypertension: the chicken and the egg. Hepatol Int. 2018;12:24-33. [PMID: 28550391 DOI: 10.1007/s12072-017-9798-x] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 11.6] [Reference Citation Analysis]
49 Nassir F, Ibdah JA. Role of mitochondria in alcoholic liver disease. World J Gastroenterol 2014; 20(9): 2136-2142 [PMID: 24605012 DOI: 10.3748/wjg.v20.i9.2136] [Cited by in CrossRef: 59] [Cited by in F6Publishing: 58] [Article Influence: 7.4] [Reference Citation Analysis]
50 Rocco A, Compare D, Angrisani D, Zamparelli MS, Nardone G. Alcoholic disease: Liver and beyond. World J Gastroenterol 2014; 20(40): 14652-14659 [PMID: 25356028 DOI: 10.3748/wjg.v20.i40.14652] [Cited by in CrossRef: 91] [Cited by in F6Publishing: 73] [Article Influence: 11.4] [Reference Citation Analysis]
51 Moin ASM, Sathyapalan T, Atkin SL, Butler AE. Letter to the Editor: Pro-fibrotic M2 macrophage markers may increase the risk for COVID19 in type 2 diabetes with obesity. Metabolism 2020;112:154374. [PMID: 32949593 DOI: 10.1016/j.metabol.2020.154374] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
52 Zhong W, McClain CJ, Cave M, Kang YJ, Zhou Z. The role of zinc deficiency in alcohol-induced intestinal barrier dysfunction. Am J Physiol Gastrointest Liver Physiol. 2010;298:G625-G633. [PMID: 20167873 DOI: 10.1152/ajpgi.00350.2009] [Cited by in Crossref: 123] [Cited by in F6Publishing: 119] [Article Influence: 10.3] [Reference Citation Analysis]
53 Anand G, Zarrinpar A, Loomba R. Targeting Dysbiosis for the Treatment of Liver Disease. Semin Liver Dis. 2016;36:37-47. [PMID: 26870931 DOI: 10.1055/s-0035-1571276] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.0] [Reference Citation Analysis]
54 Schwenger KJ, Clermont-Dejean N, Allard JP. The role of the gut microbiome in chronic liver disease: the clinical evidence revised. JHEP Rep 2019;1:214-26. [PMID: 32039372 DOI: 10.1016/j.jhepr.2019.04.004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 9.7] [Reference Citation Analysis]
55 Wang Y, Liu Y, Sidhu A, Ma Z, McClain C, Feng W. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol. 2012;303:G32-G41. [PMID: 22538402 DOI: 10.1080/07315724.2012.10720004] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
56 de Punder K, Pruimboom L. Stress induces endotoxemia and low-grade inflammation by increasing barrier permeability. Front Immunol 2015;6:223. [PMID: 26029209 DOI: 10.3389/fimmu.2015.00223] [Cited by in Crossref: 112] [Cited by in F6Publishing: 99] [Article Influence: 16.0] [Reference Citation Analysis]
57 Zhou J, Tripathi M, Sinha RA, Singh BK, Yen PM. Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease. Hepatoma Res 2021;7:11. [PMID: 33490737 DOI: 10.20517/2394-5079.2020.134] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
58 Hofeld BC, Puppala VK, Tyagi S, Ahn KW, Anger A, Jia S, Salzman NH, Hessner MJ, Widlansky ME. Lactobacillus plantarum 299v probiotic supplementation in men with stable coronary artery disease suppresses systemic inflammation. Sci Rep 2021;11:3972. [PMID: 33597583 DOI: 10.1038/s41598-021-83252-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
59 Brandl K, Kumar V, Eckmann L. Gut-liver axis at the frontier of host-microbial interactions. Am J Physiol Gastrointest Liver Physiol. 2017;312:G413-G419. [PMID: 28232456 DOI: 10.1152/ajpgi.00361.2016] [Cited by in Crossref: 68] [Cited by in F6Publishing: 64] [Article Influence: 13.6] [Reference Citation Analysis]
60 Gaydos J, McNally A, Guo R, Vandivier RW, Simonian PL, Burnham EL. Alcohol abuse and smoking alter inflammatory mediator production by pulmonary and systemic immune cells. Am J Physiol Lung Cell Mol Physiol 2016;310:L507-18. [PMID: 26747782 DOI: 10.1152/ajplung.00242.2015] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
61 Dong TS, Jacobs JP, Hussain SK. Microbial Profiles of Cirrhosis in the Human Small Intestine. Curr Gastroenterol Rep 2019;21:50. [PMID: 31444636 DOI: 10.1007/s11894-019-0717-2] [Reference Citation Analysis]
62 Iruzubieta P, Terán &, Crespo J, Fábrega E. Vitamin D deficiency in chronic liver disease. World J Hepatol 2014; 6(12): 901-915 [PMID: 25544877 DOI: 10.4254/wjh.v6.i12.901] [Cited by in Crossref: 56] [Cited by in F6Publishing: 45] [Article Influence: 7.0] [Reference Citation Analysis]
63 Bi C, Xiao G, Liu C, Yan J, Chen J, Si W, Zhang J, Liu Z. Molecular Immune Mechanism of Intestinal Microbiota and Their Metabolites in the Occurrence and Development of Liver Cancer. Front Cell Dev Biol 2021;9:702414. [PMID: 34957088 DOI: 10.3389/fcell.2021.702414] [Reference Citation Analysis]
64 Chang Y, Liu QY, Zhang Q, Rong YM, Lu CZ, Li H. Role of nutritional status and nutritional support in outcome of hepatitis B virus-associated acute-on-chronic liver failure. World J Gastroenterol 2020; 26(29): 4288-4301 [PMID: 32848334 DOI: 10.3748/wjg.v26.i29.4288] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
65 Llovet JM, Castet F, Heikenwalder M, Maini MK, Mazzaferro V, Pinato DJ, Pikarsky E, Zhu AX, Finn RS. Immunotherapies for hepatocellular carcinoma. Nat Rev Clin Oncol 2021. [PMID: 34764464 DOI: 10.1038/s41571-021-00573-2] [Reference Citation Analysis]
66 Kirpich IA, Feng W, Wang Y, Liu Y, Barker DF, Barve SS, McClain CJ. The type of dietary fat modulates intestinal tight junction integrity, gut permeability, and hepatic toll-like receptor expression in a mouse model of alcoholic liver disease. Alcohol Clin Exp Res. 2012;36:835-846. [PMID: 22150547 DOI: 10.1111/j.1530-0277.2011.01673.x] [Cited by in Crossref: 75] [Cited by in F6Publishing: 77] [Article Influence: 6.8] [Reference Citation Analysis]
67 Gonzalez-Quintela A, Alonso M, Campos J, Vizcaino L, Loidi L, Gude F. Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 2013;8:e54600. [PMID: 23349936 DOI: 10.1371/journal.pone.0054600] [Cited by in Crossref: 114] [Cited by in F6Publishing: 111] [Article Influence: 12.7] [Reference Citation Analysis]
68 Zhou Z, Wang L, Song Z, Saari JT, McClain CJ, Kang YJ. Abrogation of nuclear factor-kappaB activation is involved in zinc inhibition of lipopolysaccharide-induced tumor necrosis factor-alpha production and liver injury. Am J Pathol. 2004;164:1547-1556. [PMID: 15111301 DOI: 10.1016/s0002-9440(10)63713-3] [Cited by in Crossref: 62] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
69 Wan Saudi WS, Sjöblom M. Neuropeptide S reduces duodenal bicarbonate secretion and ethanol-induced increases in duodenal motility in rats. PLoS One 2017;12:e0175312. [PMID: 28384243 DOI: 10.1371/journal.pone.0175312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
70 Shi H, Dong L, Dang X, Liu Y, Jiang J, Wang Y, Lu X, Guo X. Effect of chlorogenic acid on LPS-induced proinflammatory signaling in hepatic stellate cells. Inflamm Res. 2013;62:581-587. [PMID: 23483217 DOI: 10.1007/s00011-013-0610-7] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 6.2] [Reference Citation Analysis]
71 Campion D, Giovo I, Ponzo P, Saracco GM, Balzola F, Alessandria C. Dietary approach and gut microbiota modulation for chronic hepatic encephalopathy in cirrhosis. World J Hepatol 2019; 11(6): 489-512 [PMID: 31293718 DOI: 10.4254/wjh.v11.i6.489] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
72 Zhong W, Zhao Y, McClain CJ, Kang YJ, Zhou Z. Inactivation of hepatocyte nuclear factor-4{alpha} mediates alcohol-induced downregulation of intestinal tight junction proteins. Am J Physiol Gastrointest Liver Physiol. 2010;299:G643-G651. [PMID: 20576917 DOI: 10.1152/ajpgi.00515.2009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 38] [Article Influence: 3.4] [Reference Citation Analysis]
73 Mega A, Marzi L, Kob M, Piccin A, Floreani A. Food and Nutrition in the Pathogenesis of Liver Damage. Nutrients 2021;13:1326. [PMID: 33923822 DOI: 10.3390/nu13041326] [Reference Citation Analysis]
74 Mackus M, Adams S, Barzilay A, Benson S, Blau L, Iversen J, Johnson SJ, Keshavarzian A, Scholey A, Smith GS, Trela C, Vatsalya V, Verster JC. Proceeding of the 8th Alcohol Hangover Research Group Meeting. Curr Drug Abuse Rev 2016;9:106-12. [PMID: 28034278 DOI: 10.2174/1874473709666161229121527] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
75 Oz HS, Chen TS, Neuman M. Nutrition intervention: a strategy against systemic inflammatory syndrome. JPEN J Parenter Enteral Nutr 2009;33:380-9. [PMID: 19380752 DOI: 10.1177/0148607108327194] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 2.2] [Reference Citation Analysis]
76 Maksan SM, Ryschich E, Ülger Z, Gebhard MM, Schmidt J. Disturbance of hepatic and intestinal microcirculation in experimental liver cirrhosis. World J Gastroenterol 2005; 11(6): 846-849 [PMID: 15682478 DOI: 10.3748/wjg.v11.i6.846] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
77 Boye A, Zou YH, Yang Y. Metabolic derivatives of alcohol and the molecular culprits of fibro-hepatocarcinogenesis: Allies or enemies? World J Gastroenterol 2016; 22(1): 50-71 [PMID: 26755860 DOI: 10.3748/wjg.v22.i1.50] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
78 Ostaff MJ, Schäfer C, Courth L, Stebe SR, Ott G, Stange EF, Wehkamp J. Chronic Heavy Alcohol Use is Associated with Upregulated Paneth Cell Antimicrobials in Gastric Mucosa. Clin Transl Gastroenterol 2015;6:e103. [PMID: 26181292 DOI: 10.1038/ctg.2015.26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
79 Mihm S. Danger-Associated Molecular Patterns (DAMPs): Molecular Triggers for Sterile Inflammation in the Liver. Int J Mol Sci 2018;19:E3104. [PMID: 30309020 DOI: 10.3390/ijms19103104] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 12.8] [Reference Citation Analysis]
80 Chen P, Miyamoto Y, Mazagova M, Lee KC, Eckmann L, Schnabl B. Microbiota Protects Mice Against Acute Alcohol-Induced Liver Injury. Alcohol Clin Exp Res 2015;39:2313-23. [PMID: 26556636 DOI: 10.1111/acer.12900] [Cited by in Crossref: 65] [Cited by in F6Publishing: 59] [Article Influence: 9.3] [Reference Citation Analysis]
81 Hsu TY, Shih HM, Wang YC, Lin LC, He GY, Chen CY, Kao CH, Chen CH, Chen WK, Yang TY. Effect of Alcoholic Intoxication on the Risk of Inflammatory Bowel Disease: A Nationwide Retrospective Cohort Study. PLoS One 2016;11:e0165411. [PMID: 27802288 DOI: 10.1371/journal.pone.0165411] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
82 Parker R, Kim SJ, Gao B. Alcohol, adipose tissue and liver disease: mechanistic links and clinical considerations. Nat Rev Gastroenterol Hepatol. 2018;15:50-59. [PMID: 28930290 DOI: 10.1038/nrgastro.2017.116] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 11.6] [Reference Citation Analysis]
83 Hartmann P, Chen WC, Schnabl B. The intestinal microbiome and the leaky gut as therapeutic targets in alcoholic liver disease. Front Physiol 2012;3:402. [PMID: 23087650 DOI: 10.3389/fphys.2012.00402] [Cited by in Crossref: 61] [Cited by in F6Publishing: 58] [Article Influence: 6.1] [Reference Citation Analysis]
84 Camilleri M, Lyle BJ, Madsen KL, Sonnenburg J, Verbeke K, Wu GD. Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations. Am J Physiol Gastrointest Liver Physiol 2019;317:G17-39. [PMID: 31125257 DOI: 10.1152/ajpgi.00063.2019] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 7.3] [Reference Citation Analysis]
85 Choudhry MA, Chaudry IH. Alcohol, burn injury, and the intestine. J Emerg Trauma Shock. 2008;1:81-87. [PMID: 19561986 DOI: 10.4103/0974-2700.43187] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
86 Albillos A, Martin-Mateos R, Van der Merwe S, Wiest R, Jalan R, Álvarez-Mon M. Cirrhosis-associated immune dysfunction. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34703031 DOI: 10.1038/s41575-021-00520-7] [Reference Citation Analysis]
87 He LH, Yao DH, Wang LY, Zhang L, Bai XL. Gut Microbiome-Mediated Alteration of Immunity, Inflammation, and Metabolism Involved in the Regulation of Non-alcoholic Fatty Liver Disease. Front Microbiol 2021;12:761836. [PMID: 34795655 DOI: 10.3389/fmicb.2021.761836] [Reference Citation Analysis]
88 Ntandja Wandji LC, Gnemmi V, Mathurin P, Louvet A. Combined alcoholic and non-alcoholic steatohepatitis. JHEP Rep 2020;2:100101. [PMID: 32514497 DOI: 10.1016/j.jhepr.2020.100101] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
89 Gu M, Samuelson DR, Taylor CM, Molina PE, Luo M, Siggins RW, Shellito JE, Welsh DA. Alcohol-associated intestinal dysbiosis alters mucosal-associated invariant T-cell phenotype and function. Alcohol Clin Exp Res 2021;45:934-47. [PMID: 33704802 DOI: 10.1111/acer.14589] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
90 Paganoni R, Lechel A, Vujic Spasic M. Iron at the Interface of Hepatocellular Carcinoma. Int J Mol Sci 2021;22:4097. [PMID: 33921027 DOI: 10.3390/ijms22084097] [Reference Citation Analysis]
91 Ceccarelli S, Nobili V, Alisi A. Toll-like receptor-mediated signaling cascade as a regulator of the inflammation network during alcoholic liver disease. World J Gastroenterol 2014; 20(44): 16443-16451 [PMID: 25469012 DOI: 10.3748/wjg.v20.i44.16443] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
92 Monnig MA, Kahler CW, Cioe PA, Monti PM, Mayer KH, Pantalone DW, Cohen RA, Ramratnam B. Markers of Microbial Translocation and Immune Activation Predict Cognitive Processing Speed in Heavy-Drinking Men Living with HIV. Microorganisms 2017;5:E64. [PMID: 28934108 DOI: 10.3390/microorganisms5040064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
93 Szabo G, Petrasek J. Gut-liver axis and sterile signals in the development of alcoholic liver disease. Alcohol Alcohol 2017;52:414-24. [PMID: 28482064 DOI: 10.1093/alcalc/agx025] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
94 Sonnenberg GF, Monticelli LA, Alenghat T, Fung TC, Hutnick NA, Kunisawa J, Shibata N, Grunberg S, Sinha R, Zahm AM, Tardif MR, Sathaliyawala T, Kubota M, Farber DL, Collman RG, Shaked A, Fouser LA, Weiner DB, Tessier PA, Friedman JR, Kiyono H, Bushman FD, Chang KM, Artis D. Innate lymphoid cells promote anatomical containment of lymphoid-resident commensal bacteria. Science 2012;336:1321-5. [PMID: 22674331 DOI: 10.1126/science.1222551] [Cited by in Crossref: 509] [Cited by in F6Publishing: 479] [Article Influence: 50.9] [Reference Citation Analysis]
95 Li F, Duan K, Wang C, McClain C, Feng W. Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol Res Pract 2016;2016:5491465. [PMID: 26839540 DOI: 10.1155/2016/5491465] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 4.6] [Reference Citation Analysis]
96 Li T, Chiang JYL. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. Hepatobiliary Surg Nutr 2020;9:152-69. [PMID: 32355674 DOI: 10.21037/hbsn.2019.09.03] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
97 Kirpich IA, Petrosino J, Ajami N, Feng W, Wang Y, Liu Y, Beier JI, Barve SS, Yin X, Wei X, Zhang X, McClain CJ. Saturated and Unsaturated Dietary Fats Differentially Modulate Ethanol-Induced Changes in Gut Microbiome and Metabolome in a Mouse Model of Alcoholic Liver Disease. Am J Pathol 2016;186:765-76. [PMID: 27012191 DOI: 10.1016/j.ajpath.2015.11.017] [Cited by in Crossref: 50] [Cited by in F6Publishing: 45] [Article Influence: 8.3] [Reference Citation Analysis]
98 Gao B, Emami A, Nath S, Schnabl B. Microbial Products and Metabolites Contributing to Alcohol-Related Liver Disease. Mol Nutr Food Res 2021;65:e2000023. [PMID: 32583604 DOI: 10.1002/mnfr.202000023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
99 Wu R, Li JX. Toll-Like Receptor 4 Signaling and Drug Addiction. Front Pharmacol 2020;11:603445. [PMID: 33424612 DOI: 10.3389/fphar.2020.603445] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
100 Gan Y, Tong J, Zhou X, Long X, Pan Y, Liu W, Zhao X. Hepatoprotective Effect of Lactobacillus plantarum HFY09 on Ethanol-Induced Liver Injury in Mice. Front Nutr 2021;8:684588. [PMID: 34249992 DOI: 10.3389/fnut.2021.684588] [Reference Citation Analysis]
101 Fukui H. Gut Microbiota and Host Reaction in Liver Diseases. Microorganisms. 2015;3:759-791. [PMID: 27682116 DOI: 10.3390/microorganisms3040759] [Cited by in Crossref: 22] [Cited by in F6Publishing: 28] [Article Influence: 3.1] [Reference Citation Analysis]
102 Li F, Duan K, Wang C, McClain C, Feng W. Probiotics and Alcoholic Liver Disease: Treatment and Potential Mechanisms. Gastroenterol Res Pract. 2016;2016:5491465. [PMID: 26839540 DOI: 10.1155/2016/5491465.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Martínez-Esparza M, Tristán-Manzano M, Ruiz-Alcaraz AJ, García-Peñarrubia P. Inflammatory status in human hepatic cirrhosis. World J Gastroenterol 2015; 21(41): 11522-11541 [PMID: 26556984 DOI: 10.3748/wjg.v21.i41.11522] [Cited by in CrossRef: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.0] [Reference Citation Analysis]
104 Karoly HC, Bidwell LC, Mueller RL, Hutchison KE. Investigating the Relationships Between Alcohol Consumption, Cannabis Use, and Circulating Cytokines: A Preliminary Analysis. Alcohol Clin Exp Res 2018;42:531-9. [PMID: 29286537 DOI: 10.1111/acer.13592] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
105 Song M, Chen T, Prough RA, Cave MC, McClain CJ. Chronic Alcohol Consumption Causes Liver Injury in High-Fructose-Fed Male Mice Through Enhanced Hepatic Inflammatory Response. Alcohol Clin Exp Res 2016;40:518-28. [PMID: 26858005 DOI: 10.1111/acer.12994] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
106 Chen P, Torralba M, Tan J, Embree M, Zengler K, Stärkel P, van Pijkeren JP, DePew J, Loomba R, Ho SB. Supplementation of saturated long-chain fatty acids maintains intestinal eubiosis and reduces ethanol-induced liver injury in mice. Gastroenterology. 2015;148:203-214.e16. [PMID: 25239591 DOI: 10.1053/j.gastro.2014.09.014] [Cited by in Crossref: 154] [Cited by in F6Publishing: 153] [Article Influence: 19.3] [Reference Citation Analysis]
107 Gupta H, Youn GS, Shin MJ, Suk KT. Role of Gut Microbiota in Hepatocarcinogenesis. Microorganisms. 2019;7:pii: E121. [PMID: 31060311 DOI: 10.3390/microorganisms7050121] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 13.0] [Reference Citation Analysis]
108 Kim SH, Lee W, Kwon D, Lee S, Son SW, Seo MS, Kim KS, Lee YH, Kim S, Jung YS. Metabolomic Analysis of the Liver of a Dextran Sodium Sulfate-Induced Acute Colitis Mouse Model: Implications of the Gut-Liver Connection. Cells 2020;9:E341. [PMID: 32024178 DOI: 10.3390/cells9020341] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
109 Huang MC, Chung RH, Lin PH, Kuo HW, Liu TH, Chen YY, Chen ACH, Liu YL. Increase in plasma CCL11 (Eotaxin-1) in patients with alcohol dependence and changes during detoxification. Brain Behav Immun 2021;99:83-90. [PMID: 34571176 DOI: 10.1016/j.bbi.2021.09.016] [Reference Citation Analysis]
110 Gupta H, Suk KT, Kim DJ. Gut Microbiota at the Intersection of Alcohol, Brain, and the Liver. J Clin Med 2021;10:541. [PMID: 33540624 DOI: 10.3390/jcm10030541] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
111 Pinzone MR, Celesia BM, Di Rosa M, Cacopardo B, Nunnari G. Microbial translocation in chronic liver diseases. Int J Microbiol 2012;2012:694629. [PMID: 22848224 DOI: 10.1155/2012/694629] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 5.4] [Reference Citation Analysis]
112 Ballway JW, Song BJ. Translational Approaches with Antioxidant Phytochemicals against Alcohol-Mediated Oxidative Stress, Gut Dysbiosis, Intestinal Barrier Dysfunction, and Fatty Liver Disease. Antioxidants (Basel) 2021;10:384. [PMID: 33806556 DOI: 10.3390/antiox10030384] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
113 Shimizu J, Okazaki S, Nagoya S, Takahashi N, Kanaya K, Mizuo K, Hyodoh H, Watanabe S, Yamashita T. Susceptibility of Males, but Not Females to Developing Femoral Head Osteonecrosis in Response to Alcohol Consumption. PLoS One 2016;11:e0165490. [PMID: 27788269 DOI: 10.1371/journal.pone.0165490] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
114 Zhong W, Li Q, Zhang W, Sun Q, Sun X, Zhou Z. Modulation of Intestinal Barrier and Bacterial Endotoxin Production Contributes to the Beneficial Effect of Nicotinic Acid on Alcohol-Induced Endotoxemia and Hepatic Inflammation in Rats. Biomolecules 2015;5:2643-58. [PMID: 26501337 DOI: 10.3390/biom5042643] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
115 Fukui H, Wiest R. Changes of Intestinal Functions in Liver Cirrhosis. Inflamm Intest Dis. 2016;1:24-40. [PMID: 29922655 DOI: 10.1159/000444436] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
116 Aragonès G, González-García S, Aguilar C, Richart C, Auguet T. Gut Microbiota-Derived Mediators as Potential Markers in Nonalcoholic Fatty Liver Disease. Biomed Res Int 2019;2019:8507583. [PMID: 30719448 DOI: 10.1155/2019/8507583] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
117 Shan Z, Ju C. Hepatic Macrophages in Liver Injury. Front Immunol 2020;11:322. [PMID: 32362892 DOI: 10.3389/fimmu.2020.00322] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
118 Hartmann P, Chen P, Wang HJ, Wang L, McCole DF, Brandl K, Stärkel P, Belzer C, Hellerbrand C, Tsukamoto H, Ho SB, Schnabl B. Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice. Hepatology 2013;58:108-19. [PMID: 23408358 DOI: 10.1002/hep.26321] [Cited by in Crossref: 135] [Cited by in F6Publishing: 127] [Article Influence: 15.0] [Reference Citation Analysis]
119 Kovač U, Žužek Z, Raspor Dall'Olio L, Pohar K, Ihan A, Moškon M, Rozman D, Starčič Erjavec M. Escherichia coli Affects Expression of Circadian Clock Genes in Human Hepatoma Cells. Microorganisms 2021;9:869. [PMID: 33920679 DOI: 10.3390/microorganisms9040869] [Reference Citation Analysis]
120 Nowak AJ, Relja B. The Impact of Acute or Chronic Alcohol Intake on the NF-κB Signaling Pathway in Alcohol-Related Liver Disease. Int J Mol Sci 2020;21:E9407. [PMID: 33321885 DOI: 10.3390/ijms21249407] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
121 Shasthry SM. Fecal microbiota transplantation in alcohol related liver diseases. Clin Mol Hepatol 2020;26:294-301. [PMID: 32570299 DOI: 10.3350/cmh.2020.0057] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
122 Akiba Y, Maruta K, Takajo T, Narimatsu K, Said H, Kato I, Kuwahara A, Kaunitz JD. Lipopolysaccharides transport during fat absorption in rodent small intestine. Am J Physiol Gastrointest Liver Physiol 2020;318:G1070-87. [PMID: 32390462 DOI: 10.1152/ajpgi.00079.2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
123 Hartmann P, Seebauer CT, Schnabl B. Alcoholic liver disease: the gut microbiome and liver cross talk. Alcohol Clin Exp Res. 2015;39:763-775. [PMID: 25872593 DOI: 10.1111/acer.12704] [Cited by in Crossref: 126] [Cited by in F6Publishing: 122] [Article Influence: 21.0] [Reference Citation Analysis]
124 Malaguarnera G, Giordano M, Nunnari G, Bertino G, Malaguarnera M. Gut microbiota in alcoholic liver disease: Pathogenetic role and therapeutic perspectives. World J Gastroenterol 2014; 20(44): 16639-16648 [PMID: 25469033 DOI: 10.3748/wjg.v20.i44.16639] [Cited by in CrossRef: 75] [Cited by in F6Publishing: 67] [Article Influence: 9.4] [Reference Citation Analysis]
125 Shao T, Zhao C, Li F, Gu Z, Liu L, Zhang L, Wang Y, He L, Liu Y, Liu Q, Chen Y, Donde H, Wang R, Jala VR, Barve S, Chen SY, Zhang X, Chen Y, McClain CJ, Feng W. Intestinal HIF-1α deletion exacerbates alcoholic liver disease by inducing intestinal dysbiosis and barrier dysfunction. J Hepatol 2018;69:886-95. [PMID: 29803899 DOI: 10.1016/j.jhep.2018.05.021] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 13.5] [Reference Citation Analysis]
126 Groschwitz KR, Hogan SP. Intestinal barrier function: molecular regulation and disease pathogenesis. J Allergy Clin Immunol 2009;124:3-20; quiz 21-2. [PMID: 19560575 DOI: 10.1016/j.jaci.2009.05.038] [Cited by in Crossref: 794] [Cited by in F6Publishing: 748] [Article Influence: 61.1] [Reference Citation Analysis]
127 Vanuytsel T, Tack J, Farre R. The Role of Intestinal Permeability in Gastrointestinal Disorders and Current Methods of Evaluation. Front Nutr 2021;8:717925. [PMID: 34513903 DOI: 10.3389/fnut.2021.717925] [Reference Citation Analysis]
128 McDonald EA, Stuart R, Joshi A, Wu HW, Olveda RM, Acosta LP, Tallo V, Baltazar PI, Bailey JA, Kurtis JD, Friedman JF. Endotoxin at the Maternal-Fetal Interface in a Resource-Constrained Setting: Risk Factors and Associated Birth Outcomes. Am J Trop Med Hyg 2018;99:495-501. [PMID: 29968554 DOI: 10.4269/ajtmh.17-0949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
129 Park JK, Shao M, Kim MY, Baik SK, Cho MY, Utsumi T, Satoh A, Ouyang X, Chung C, Iwakiri Y. An endoplasmic reticulum protein, Nogo-B, facilitates alcoholic liver disease through regulation of kupffer cell polarization. Hepatology. 2017;65:1720-1734. [PMID: 28090670 DOI: 10.1002/hep.29051] [Cited by in Crossref: 36] [Cited by in F6Publishing: 35] [Article Influence: 7.2] [Reference Citation Analysis]
130 Neuman MG, French SW, French BA, Seitz HK, Cohen LB, Mueller S, Osna NA, Kharbanda KK, Seth D, Bautista A. Alcoholic and non-alcoholic steatohepatitis. Exp Mol Pathol. 2014;97:492-510. [PMID: 25217800 DOI: 10.1016/j.yexmp.2014.09.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 5.1] [Reference Citation Analysis]
131 Puri P, Liangpunsakul S, Christensen JE, Shah VH, Kamath PS, Gores GJ, Walker S, Comerford M, Katz B, Borst A, Yu Q, Kumar DP, Mirshahi F, Radaeva S, Chalasani NP, Crabb DW, Sanyal AJ; TREAT Consortium. The circulating microbiome signature and inferred functional metagenomics in alcoholic hepatitis. Hepatology 2018;67:1284-302. [PMID: 29083504 DOI: 10.1002/hep.29623] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 14.5] [Reference Citation Analysis]
132 Bishehsari F, Preuss F, Mirbagheri SS, Zhang L, Shaikh M, Keshavarzian A. Interaction of alcohol with time of eating on markers of circadian dyssynchrony and colon tissue injury. Chem Biol Interact 2020;325:109132. [PMID: 32437693 DOI: 10.1016/j.cbi.2020.109132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
133 Iruzubieta P, Medina JM, Fernández-López R, Crespo J, de la Cruz F. A Role for Gut Microbiome Fermentative Pathways in Fatty Liver Disease Progression. J Clin Med 2020;9:E1369. [PMID: 32392712 DOI: 10.3390/jcm9051369] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
134 McCullough RL, McMullen MR, Poulsen KL, Kim A, Medof ME, Nagy LE. Anaphylatoxin Receptors C3aR and C5aR1 Are Important Factors That Influence the Impact of Ethanol on the Adipose Secretome. Front Immunol 2018;9:2133. [PMID: 30294325 DOI: 10.3389/fimmu.2018.02133] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
135 Dhanda AD, Collins PL. Immune dysfunction in acute alcoholic hepatitis. World J Gastroenterol 2015; 21(42): 11904-11913 [PMID: 26576079 DOI: 10.3748/wjg.v21.i42.11904] [Cited by in CrossRef: 25] [Cited by in F6Publishing: 23] [Article Influence: 3.6] [Reference Citation Analysis]
136 Kirpich IA, Feng W, Wang Y, Liu Y, Beier JI, Arteel GE, Falkner KC, Barve SS, McClain CJ. Ethanol and dietary unsaturated fat (corn oil/linoleic acid enriched) cause intestinal inflammation and impaired intestinal barrier defense in mice chronically fed alcohol. Alcohol. 2013;47:257-264. [PMID: 23453163 DOI: 10.1016/j.alcohol.2013.01.005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 4.6] [Reference Citation Analysis]
137 Parlesak A, Schäfer C, Bode C. IgA against gut-derived endotoxins: does it contribute to suppression of hepatic inflammation in alcohol-induced liver disease? Dig Dis Sci. 2002;47:760-766. [PMID: 11991606 DOI: 10.1023/A:1014783815433] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
138 Chen P, Schnabl B. Host-microbiome interactions in alcoholic liver disease. Gut Liver. 2014;8:237-241. [PMID: 24827618 DOI: 10.5009/gnl.2014.8.3.237] [Cited by in Crossref: 51] [Cited by in F6Publishing: 44] [Article Influence: 6.4] [Reference Citation Analysis]
139 Bull-Otterson L, Feng W, Kirpich I, Wang Y, Qin X, Liu Y, Gobejishvili L, Joshi-Barve S, Ayvaz T, Petrosino J, Kong M, Barker D, McClain C, Barve S. Metagenomic analyses of alcohol induced pathogenic alterations in the intestinal microbiome and the effect of Lactobacillus rhamnosus GG treatment. PLoS One. 2013;8:e53028. [PMID: 23326376 DOI: 10.1371/journal.pone.0053028] [Cited by in Crossref: 272] [Cited by in F6Publishing: 269] [Article Influence: 30.2] [Reference Citation Analysis]
140 Zhou Z, Wang L, Song Z, Lambert JC, McClain CJ, Kang YJ. A critical involvement of oxidative stress in acute alcohol-induced hepatic TNF-alpha production. Am J Pathol. 2003;163:1137-1146. [PMID: 12937155 DOI: 10.1016/s0002-9440(10)63473-6] [Cited by in Crossref: 139] [Cited by in F6Publishing: 63] [Article Influence: 7.3] [Reference Citation Analysis]
141 Wang Y, Liu Y, Sidhu A, Ma Z, McClain C, Feng W. Lactobacillus rhamnosus GG culture supernatant ameliorates acute alcohol-induced intestinal permeability and liver injury. Am J Physiol Gastrointest Liver Physiol. 2012;303:G32-G41. [PMID: 22538402 DOI: 10.1152/ajpgi.00024.2012] [Cited by in Crossref: 121] [Cited by in F6Publishing: 124] [Article Influence: 12.1] [Reference Citation Analysis]
142 Liu Z, Zhang Z, Huang M, Sun X, Liu B, Guo Q, Chang Q, Duan Z. Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments. BMC Gastroenterol 2018;18:112. [PMID: 29996772 DOI: 10.1186/s12876-018-0842-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
143 Suzuki T. Regulation of intestinal epithelial permeability by tight junctions. Cell Mol Life Sci. 2013;70:631-659. [PMID: 22782113 DOI: 10.1007/s00018-012-1070-x] [Cited by in Crossref: 569] [Cited by in F6Publishing: 555] [Article Influence: 56.9] [Reference Citation Analysis]
144 Davis BT 4th, Voigt RM, Shaikh M, Forsyth CB, Keshavarzian A. CREB Protein Mediates Alcohol-Induced Circadian Disruption and Intestinal Permeability. Alcohol Clin Exp Res 2017;41:2007-14. [PMID: 28960346 DOI: 10.1111/acer.13513] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
145 Hamza AR, Krasniqi AS, Srinivasan PK, Afify M, Bleilevens C, Klinge U, Tolba RH. Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection. World J Gastroenterol 2014; 20(40): 14841-14854 [PMID: 25356044 DOI: 10.3748/wjg.v20.i40.14841] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
146 Ferrier L, Bérard F, Debrauwer L, Chabo C, Langella P, Buéno L, Fioramonti J. Impairment of the intestinal barrier by ethanol involves enteric microflora and mast cell activation in rodents. Am J Pathol 2006;168:1148-54. [PMID: 16565490 DOI: 10.2353/ajpath.2006.050617] [Cited by in Crossref: 159] [Cited by in F6Publishing: 154] [Article Influence: 9.9] [Reference Citation Analysis]
147 Shi QZ, Wang LW, Zhang W, Gong ZJ. Betaine inhibits Toll-like receptor 4 expression in rats with ethanol-induced liver injury. World J Gastroenterol 2010; 16(7): 897-903 [PMID: 20143470 DOI: 10.3748/wjg.v16.i7.897] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
148 Volynets V, Reichold A, Bárdos G, Rings A, Bleich A, Bischoff SC. Assessment of the Intestinal Barrier with Five Different Permeability Tests in Healthy C57BL/6J and BALB/cJ Mice. Dig Dis Sci 2016;61:737-46. [PMID: 26520109 DOI: 10.1007/s10620-015-3935-y] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 5.9] [Reference Citation Analysis]
149 Abdullah Z, Knolle PA. Liver macrophages in healthy and diseased liver. Pflugers Arch 2017;469:553-60. [PMID: 28293730 DOI: 10.1007/s00424-017-1954-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
150 Liu J. Ethanol and liver: Recent insights into the mechanisms of ethanol-induced fatty liver. World J Gastroenterol 2014; 20(40): 14672-14685 [PMID: 25356030 DOI: 10.3748/wjg.v20.i40.14672] [Cited by in CrossRef: 62] [Cited by in F6Publishing: 55] [Article Influence: 7.8] [Reference Citation Analysis]
151 Elnagdy M, Barve S, McClain C, Gobejishvili L. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules 2020;10:E1433. [PMID: 33050657 DOI: 10.3390/biom10101433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
152 Kim DH, Sim Y, Hwang JH, Kwun IS, Lim JH, Kim J, Kim JI, Baek MC, Akbar M, Seo W, Kim DK, Song BJ, Cho YE. Ellagic Acid Prevents Binge Alcohol-Induced Leaky Gut and Liver Injury through Inhibiting Gut Dysbiosis and Oxidative Stress. Antioxidants (Basel) 2021;10:1386. [PMID: 34573017 DOI: 10.3390/antiox10091386] [Reference Citation Analysis]
153 Hendrikx T, Schnabl B. Antimicrobial proteins: intestinal guards to protect against liver disease. J Gastroenterol 2019;54:209-17. [PMID: 30392013 DOI: 10.1007/s00535-018-1521-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]
154 Soares JB, Pimentel-Nunes P, Roncon-Albuquerque R, Leite-Moreira A. The role of lipopolysaccharide/toll-like receptor 4 signaling in chronic liver diseases. Hepatol Int. 2010;4:659-672. [PMID: 21286336 DOI: 10.1007/s12072-010-9219-x] [Cited by in Crossref: 147] [Cited by in F6Publishing: 147] [Article Influence: 12.3] [Reference Citation Analysis]
155 Schnabl B, Brenner DA. Interactions between the intestinal microbiome and liver diseases. Gastroenterology. 2014;146:1513-1524. [PMID: 24440671 DOI: 10.1053/j.gastro.2014.01.020] [Cited by in Crossref: 487] [Cited by in F6Publishing: 468] [Article Influence: 60.9] [Reference Citation Analysis]
156 Carr RM, Correnti J. Insulin resistance in clinical and experimental alcoholic liver disease. Ann N Y Acad Sci. 2015;1353:1-20. [PMID: 25998863 DOI: 10.1111/nyas.12787] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 3.4] [Reference Citation Analysis]
157 Cassard AM, Ciocan D. Microbiota, a key player in alcoholic liver disease. Clin Mol Hepatol 2018;24:100-7. [PMID: 29268595 DOI: 10.3350/cmh.2017.0067] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 7.6] [Reference Citation Analysis]
158 Zhang X, Wang H, Yin P, Fan H, Sun L, Liu Y. Flaxseed oil ameliorates alcoholic liver disease via anti-inflammation and modulating gut microbiota in mice. Lipids Health Dis 2017;16:44. [PMID: 28228158 DOI: 10.1186/s12944-017-0431-8] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 9.6] [Reference Citation Analysis]
159 Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis 2016;1:135-45. [PMID: 29922669 DOI: 10.1159/000447252] [Cited by in Crossref: 110] [Cited by in F6Publishing: 102] [Article Influence: 18.3] [Reference Citation Analysis]
160 Bϋdingen FV, Gonzalez D, Tucker AN, Derendorf H. Relevance of Liver Failure for Anti-Infective Agents: From Pharmacokinetic Alterations to Dosage Adjustments. Ther Adv Infect Dis 2014;2:17-42. [PMID: 24949199 DOI: 10.1177/2049936113519089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
161 Jiang Y, Chowdhury S, Xu BH, Meybodi MA, Damiris K, Devalaraju S, Pyrsopoulos N. Nonalcoholic fatty liver disease is associated with worse intestinal complications in patients hospitalized for Clostridioides difficile infection. World J Hepatol 2021; 13(11): 1777-1790 [PMID: 34904045 DOI: 10.4254/wjh.v13.i11.1777] [Reference Citation Analysis]
162 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. Publisher Correction: The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol 2018;15:785. [PMID: 29785003 DOI: 10.1038/s41575-018-0031-8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
163 Leung C, Rivera L, Furness JB, Angus PW. The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol. 2016;13:412-425. [PMID: 27273168 DOI: 10.1038/nrgastro.2016.85] [Cited by in Crossref: 362] [Cited by in F6Publishing: 339] [Article Influence: 60.3] [Reference Citation Analysis]
164 Yan AW, Schnabl B. Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease. World J Hepatol 2012; 4(4): 110-118 [PMID: 22567183 DOI: 10.4254/wjh.v4.i4.110] [Cited by in Crossref: 71] [Cited by in F6Publishing: 66] [Article Influence: 7.1] [Reference Citation Analysis]
165 Sauerbruch T, Schierwagen R, Trebicka J. Managing portal hypertension in patients with liver cirrhosis. F1000Res 2018;7:F1000 Faculty Rev-533. [PMID: 29780579 DOI: 10.12688/f1000research.13943.1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 3.8] [Reference Citation Analysis]
166 Seo HY, Kim MK, Lee SH, Hwang JS, Park KG, Jang BK. Kahweol Ameliorates the Liver Inflammation through the Inhibition of NF-κB and STAT3 Activation in Primary Kupffer Cells and Primary Hepatocytes. Nutrients 2018;10:E863. [PMID: 29973533 DOI: 10.3390/nu10070863] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
167 Simbrunner B, Mandorfer M, Trauner M, Reiberger T. Gut-liver axis signaling in portal hypertension. World J Gastroenterol 2019; 25(39): 5897-5917 [PMID: 31660028 DOI: 10.3748/wjg.v25.i39.5897] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 19] [Article Influence: 8.7] [Reference Citation Analysis]
168 Jennison E, Byrne CD. The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver disease. Clin Mol Hepatol 2021;27:22-43. [PMID: 33291863 DOI: 10.3350/cmh.2020.0129] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
169 Souza-Smith FM, Siggins RW, Molina PE. Mesenteric Lymphatic-Perilymphatic Adipose Crosstalk: Role in Alcohol-Induced Perilymphatic Adipose Tissue Inflammation. Alcohol Clin Exp Res 2015;39:1380-7. [PMID: 26147204 DOI: 10.1111/acer.12796] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.1] [Reference Citation Analysis]
170 Farhadi A, Keshavarzian A, Kwasny MJ, Shaikh M, Fogg L, Lau C, Fields JZ, Forsyth CB. Effects of aspirin on gastroduodenal permeability in alcoholics and controls. Alcohol. 2010;44:447-456. [PMID: 20598487 DOI: 10.1016/j.alcohol.2010.05.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
171 Betrapally NS, Gillevet PM, Bajaj JS. Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects? Gastroenterology 2016;150:1745-1755.e3. [PMID: 26948887 DOI: 10.1053/j.gastro.2016.02.073] [Cited by in Crossref: 73] [Cited by in F6Publishing: 63] [Article Influence: 12.2] [Reference Citation Analysis]
172 Fukui H. Gut Microbiome-based Therapeutics in Liver Cirrhosis: Basic Consideration for the Next Step. J Clin Transl Hepatol 2017;5:249-60. [PMID: 28936406 DOI: 10.14218/JCTH.2017.00008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 19] [Article Influence: 1.2] [Reference Citation Analysis]
173 Aguirre Valadez JM, Rivera-Espinosa L, Méndez-Guerrero O, Chávez-Pacheco JL, García Juárez I, Torre A. Intestinal permeability in a patient with liver cirrhosis. Ther Clin Risk Manag 2016;12:1729-48. [PMID: 27920543 DOI: 10.2147/TCRM.S115902] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
174 Shao Q, Wu Y, Ji J, Xu T, Yu Q, Ma C, Liao X, Cheng F, Wang X. Interaction Mechanisms Between Major Depressive Disorder and Non-alcoholic Fatty Liver Disease. Front Psychiatry 2021;12:711835. [PMID: 34966296 DOI: 10.3389/fpsyt.2021.711835] [Reference Citation Analysis]
175 Zhang L, Wang F, Wang J, Wang Y, Fang Y. Intestinal fatty acid-binding protein mediates atherosclerotic progress through increasing intestinal inflammation and permeability. J Cell Mol Med 2020;24:5205-12. [PMID: 32220004 DOI: 10.1111/jcmm.15173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
176 Boule LA, Ju C, Agudelo M, Parira T, Cannon A, Davis B, Eby J, Cresci G, Samuelson DR, Shukla P, Alrefai WA, Sureshchandra S, Pandey SC, Schnabl B, Curtis BJ, Wyatt TA, Choudhry MA, Kovacs EJ. Summary of the 2016 Alcohol and Immunology Research Interest Group (AIRIG) meeting. Alcohol 2018;66:35-43. [PMID: 29127885 DOI: 10.1016/j.alcohol.2017.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
177 Lowe PP, Gyongyosi B, Satishchandran A, Iracheta-Vellve A, Cho Y, Ambade A, Szabo G. Reduced gut microbiome protects from alcohol-induced neuroinflammation and alters intestinal and brain inflammasome expression. J Neuroinflammation. 2018;15:298. [PMID: 30368255 DOI: 10.1186/s12974-018-1328-9] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 8.3] [Reference Citation Analysis]
178 Herrera M, Molina P, Souza-Smith FM. Ethanol-induced lymphatic endothelial cell permeability via MAP-kinase regulation. Am J Physiol Cell Physiol 2021;321:C104-16. [PMID: 33909502 DOI: 10.1152/ajpcell.00039.2021] [Reference Citation Analysis]
179 Bonnet U, Selle C, Isbruch K, Isbruch K. Recurrent purpura due to alcohol-related Schamberg's disease and its association with serum immunoglobulins: a longitudinal observation of a heavy drinker. J Med Case Rep 2016;10:301. [PMID: 27799068 DOI: 10.1186/s13256-016-1065-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
180 Pradere JP, Troeger JS, Dapito DH, Mencin AA, Schwabe RF. Toll-like receptor 4 and hepatic fibrogenesis. Semin Liver Dis. 2010;30:232-244. [PMID: 20665376 DOI: 10.1055/s-0030-1255353] [Cited by in Crossref: 91] [Cited by in F6Publishing: 91] [Article Influence: 7.6] [Reference Citation Analysis]
181 Tripathi A, Debelius J, Brenner DA, Karin M, Loomba R, Schnabl B, Knight R. The gut-liver axis and the intersection with the microbiome. Nat Rev Gastroenterol Hepatol. 2018;15:397-411. [PMID: 29748586 DOI: 10.1038/s41575-018-0011-z] [Cited by in Crossref: 301] [Cited by in F6Publishing: 300] [Article Influence: 100.3] [Reference Citation Analysis]
182 Li F, McClain CJ, Feng W. Microbiome dysbiosis and alcoholic liver disease. Liver Res 2019;3:218-26. [PMID: 33868760 DOI: 10.1016/j.livres.2019.09.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
183 Yu LX, Schwabe RF. The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 2017;14:527-39. [PMID: 28676707 DOI: 10.1038/nrgastro.2017.72] [Cited by in Crossref: 176] [Cited by in F6Publishing: 168] [Article Influence: 35.2] [Reference Citation Analysis]
184 Fukui H. Increased Intestinal Permeability and Decreased Barrier Function: Does It Really Influence the Risk of Inflammation? Inflamm Intest Dis. 2016;1:135-145. [PMID: 29922669 DOI: 10.1159/000447252.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Swanson GR, Gorenz A, Shaikh M, Desai V, Forsyth C, Fogg L, Burgess HJ, Keshavarzian A. Decreased melatonin secretion is associated with increased intestinal permeability and marker of endotoxemia in alcoholics. Am J Physiol Gastrointest Liver Physiol 2015;308:G1004-11. [PMID: 25907689 DOI: 10.1152/ajpgi.00002.2015] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 3.9] [Reference Citation Analysis]
186 Kerckhoffs AP, Akkermans LM, de Smet MB, Besselink MG, Hietbrink F, Bartelink IH, Busschers WB, Samsom M, Renooij W. Intestinal permeability in irritable bowel syndrome patients: effects of NSAIDs. Dig Dis Sci. 2010;55:716-723. [PMID: 19255843 DOI: 10.1007/s10620-009-0765-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
187 Byun JS, Yi HS. Hepatic Immune Microenvironment in Alcoholic and Nonalcoholic Liver Disease. Biomed Res Int. 2017;2017:6862439. [PMID: 28852648 DOI: 10.1155/2017/6862439] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
188 Qin HM, Wu CM, Li HT, Song JX. Role of andrographolide in the permeability of intestinal tract of cirrhosis rats and its clinical significance. Shijie Huaren Xiaohua Zazhi 2008; 16(8): 839-843 [DOI: 10.11569/wcjd.v16.i8.839] [Reference Citation Analysis]
189 Tian DA, Hong JM, Liu NZ, Wang JL. Effects of L-arginine on expression of nitric oxide synthase and oxidative stress in rat liver tissues with alcoholic hepatic steatosis. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 702-705 [DOI: 10.11569/wcjd.v12.i3.702] [Reference Citation Analysis]
190 Rao R. Endotoxemia and gut barrier dysfunction in alcoholic liver disease. Hepatology. 2009;50:638-644. [PMID: 19575462 DOI: 10.1002/hep.23009] [Cited by in Crossref: 271] [Cited by in F6Publishing: 266] [Article Influence: 20.8] [Reference Citation Analysis]
191 Zhao M, Chen C, Yuan Z, Li W, Zhang M, Cui N, Duan Y, Zhang X, Zhang P. Dietary Bacillus subtilis supplementation alleviates alcohol-induced liver injury by maintaining intestinal integrity and gut microbiota homeostasis in mice. Exp Ther Med 2021;22:1312. [PMID: 34630666 DOI: 10.3892/etm.2021.10747] [Reference Citation Analysis]
192 Wang Y, Chen H, Chen Q, Jiao FZ, Zhang WB, Gong ZJ. The Protective Mechanism of CAY10683 on Intestinal Mucosal Barrier in Acute Liver Failure through LPS/TLR4/MyD88 Pathway. Mediators Inflamm 2018;2018:7859601. [PMID: 29725271 DOI: 10.1155/2018/7859601] [Cited by in Crossref: 6] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
193 Yoon YH, Chen CM, Slater ME, Jung MK, White AM. Trends in Premature Deaths From Alcoholic Liver Disease in the U.S., 1999-2018. Am J Prev Med 2020;59:469-80. [PMID: 32863077 DOI: 10.1016/j.amepre.2020.04.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
194 Sakurai Y, Kubota N, Yamauchi T, Kadowaki T. Role of Insulin Resistance in MAFLD. Int J Mol Sci 2021;22:4156. [PMID: 33923817 DOI: 10.3390/ijms22084156] [Reference Citation Analysis]
195 Zhong W, Zhou Z. Alterations of the gut microbiome and metabolome in alcoholic liver disease. World J Gastrointest Pathophysiol 2014; 5(4): 514-522 [PMID: 25400995 DOI: 10.4291/wjgp.v5.i4.514] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
196 Khoshbin K, Camilleri M. Effects of dietary components on intestinal permeability in health and disease. Am J Physiol Gastrointest Liver Physiol 2020;319:G589-608. [PMID: 32902315 DOI: 10.1152/ajpgi.00245.2020] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
197 Yoseph BP, Breed E, Overgaard CE, Ward CJ, Liang Z, Wagener ME, Lexcen DR, Lusczek ER, Beilman GJ, Burd EM, Farris AB, Guidot DM, Koval M, Ford ML, Coopersmith CM. Chronic alcohol ingestion increases mortality and organ injury in a murine model of septic peritonitis. PLoS One. 2013;8:e62792. [PMID: 23717394 DOI: 10.1371/journal.pone.0062792] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 4.3] [Reference Citation Analysis]
198 Lee S, Son SC, Han MJ, Kim WJ, Kim SH, Kim HR, Jeon WK, Park KH, Shin MG. Increased intestinal macromolecular permeability and urine nitrite excretion associated with liver cirrhosis with ascites. World J Gastroenterol 2008; 14(24): 3884-3890 [PMID: 18609714 DOI: 10.3748/wjg.14.3884] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 30] [Article Influence: 1.9] [Reference Citation Analysis]
199 Arab JP, Arrese M, Shah VH. Gut microbiota in non-alcoholic fatty liver disease and alcohol-related liver disease: Current concepts and perspectives. Hepatol Res 2020;50:407-18. [PMID: 31840358 DOI: 10.1111/hepr.13473] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 6.5] [Reference Citation Analysis]
200 Downs CA, Trac D, Brewer EM, Brown LA, Helms MN. Chronic alcohol ingestion changes the landscape of the alveolar epithelium. Biomed Res Int 2013;2013:470217. [PMID: 23509726 DOI: 10.1155/2013/470217] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
201 Erickson EK, Grantham EK, Warden AS, Harris RA. Neuroimmune signaling in alcohol use disorder. Pharmacol Biochem Behav 2019;177:34-60. [PMID: 30590091 DOI: 10.1016/j.pbb.2018.12.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 53] [Article Influence: 14.3] [Reference Citation Analysis]
202 Chopyk DM, Kumar P, Raeman R, Liu Y, Smith T, Anania FA. Dysregulation of junctional adhesion molecule-A contributes to ethanol-induced barrier disruption in intestinal epithelial cell monolayers. Physiol Rep 2017;5. [PMID: 29208693 DOI: 10.14814/phy2.13541] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
203 Zhou H, Yu M, Zhao J, Martin BN, Roychowdhury S, McMullen MR, Wang E, Fox PL, Yamasaki S, Nagy LE, Li X. IRAKM-Mincle axis links cell death to inflammation: Pathophysiological implications for chronic alcoholic liver disease. Hepatology. 2016;64:1978-1993. [PMID: 27628766 DOI: 10.1002/hep.28811] [Cited by in Crossref: 32] [Cited by in F6Publishing: 37] [Article Influence: 5.3] [Reference Citation Analysis]
204 Acharya C, Bajaj JS. Gut Microbiota and Complications of Liver Disease. Gastroenterol Clin North Am. 2017;46:155-169. [PMID: 28164848 DOI: 10.1016/j.gtc.2016.09.013] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 9.8] [Reference Citation Analysis]
205 Giménez-Gómez P, Pérez-Hernández M, O'Shea E, Caso JR, Martín-Hernandez D, Cervera LA, Centelles MLG, Gutiérrez-Lopez MD, Colado MI. Changes in brain kynurenine levels via gut microbiota and gut-barrier disruption induced by chronic ethanol exposure in mice. FASEB J 2019;33:12900-14. [PMID: 31509716 DOI: 10.1096/fj.201900491RR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
206 Milosevic I, Russo E, Vujovic A, Barac A, Stevanovic O, Gitto S, Amedei A. Microbiota and viral hepatitis: State of the art of a complex matter. World J Gastroenterol 2021; 27(33): 5488-5501 [PMID: 34588747 DOI: 10.3748/wjg.v27.i33.5488] [Reference Citation Analysis]
207 Rachakonda V, Bataller R, Duarte-Rojo A. Recent advances in alcoholic hepatitis. F1000Res 2020;9:F1000 Faculty Rev-97. [PMID: 32089834 DOI: 10.12688/f1000research.20394.1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
208 Moreno-Gonzalez M, Beraza N. The Role of the Microbiome in Liver Cancer. Cancers (Basel) 2021;13:2330. [PMID: 34066064 DOI: 10.3390/cancers13102330] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
209 Gandhi CR. Pro- and Anti-fibrogenic Functions of Gram-Negative Bacterial Lipopolysaccharide in the Liver. Front Med (Lausanne) 2020;7:130. [PMID: 32373617 DOI: 10.3389/fmed.2020.00130] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
210 Kirpich IA, McClain CJ, Vatsalya V, Schwandt M, Phillips M, Falkner KC, Zhang L, Harwell C, George DT, Umhau JC. Liver Injury and Endotoxemia in Male and Female Alcohol-Dependent Individuals Admitted to an Alcohol Treatment Program. Alcohol Clin Exp Res 2017;41:747-57. [PMID: 28166367 DOI: 10.1111/acer.13346] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 3.4] [Reference Citation Analysis]
211 Al-Sadi RM, Ma TY. IL-1beta causes an increase in intestinal epithelial tight junction permeability. J Immunol. 2007;178:4641-4649. [PMID: 17372023 DOI: 10.4049/jimmunol.178.7.4641] [Cited by in Crossref: 328] [Cited by in F6Publishing: 328] [Article Influence: 21.9] [Reference Citation Analysis]
212 Kaji K, Saikawa S, Takaya H, Fujinaga Y, Furukawa M, Kitagawa K, Ozutsumi T, Kaya D, Tsuji Y, Sawada Y, Kawaratani H, Moriya K, Namisaki T, Akahane T, Mitoro A, Yoshiji H. Rifaximin Alleviates Endotoxemia with Decreased Serum Levels of Soluble CD163 and Mannose Receptor and Partial Modification of Gut Microbiota in Cirrhotic Patients. Antibiotics (Basel). 2020;9. [PMID: 32235367 DOI: 10.3390/antibiotics9040145] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
213 Bataller R, Cabezas J, Aller R, Ventura-Cots M, Abad J, Albillos A, Altamirano J, Arias-Loste MT, Bañares R, Caballería J, Caballería L, Carrión JA, Diago M, Fernández Rodríguez C, Gallego R, García-Cortes M, García-Monzón C, Genescà J, Ginés P, Hernandez-Guerra M, Jorquera F, Lligoña A, Molina E, Pareja MJ, Planas R, Tomé S, Salmerón J, Romero-Gómez M. Alcohol-related liver disease. Clinical practice guidelines. Consensus document sponsored by AEEH. Gastroenterol Hepatol 2019;42:657-76. [PMID: 31771785 DOI: 10.1016/j.gastrohep.2019.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
214 Fukui H, Wiest R. Changes of Intestinal Functions in Liver Cirrhosis. Inflamm Intest Dis. 2016;1:24-40. [PMID: 29922655 DOI: 10.1159/000444436].] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
215 André P, Laugerette F, Féart C. Metabolic Endotoxemia: A Potential Underlying Mechanism of the Relationship between Dietary Fat Intake and Risk for Cognitive Impairments in Humans? Nutrients 2019;11:E1887. [PMID: 31412673 DOI: 10.3390/nu11081887] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
216 Awad WA, Hess C, Hess M. Enteric Pathogens and Their Toxin-Induced Disruption of the Intestinal Barrier through Alteration of Tight Junctions in Chickens. Toxins (Basel) 2017;9:E60. [PMID: 28208612 DOI: 10.3390/toxins9020060] [Cited by in Crossref: 117] [Cited by in F6Publishing: 112] [Article Influence: 23.4] [Reference Citation Analysis]
217 Hoque R, Mehal WZ. Inflammasomes in pancreatic physiology and disease. Am J Physiol Gastrointest Liver Physiol 2015;308:G643-51. [PMID: 25700081 DOI: 10.1152/ajpgi.00388.2014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.6] [Reference Citation Analysis]
218 Ishibashi H, Nakamura M, Komori A, Migita K, Shimoda S. Liver architecture, cell function, and disease. Semin Immunopathol 2009;31:399-409. [PMID: 19468732 DOI: 10.1007/s00281-009-0155-6] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 6.6] [Reference Citation Analysis]
219 Wang Y, Kirpich I, Liu Y, Ma Z, Barve S, McClain CJ, Feng W. Lactobacillus rhamnosus GG treatment potentiates intestinal hypoxia-inducible factor, promotes intestinal integrity and ameliorates alcohol-induced liver injury. Am J Pathol 2011;179:2866-75. [PMID: 22093263 DOI: 10.1016/j.ajpath.2011.08.039] [Cited by in Crossref: 133] [Cited by in F6Publishing: 131] [Article Influence: 13.3] [Reference Citation Analysis]
220 Mohammad MK, Zhou Z, Cave M, Barve A, McClain CJ. Zinc and liver disease. Nutr Clin Pract. 2012;27:8-20. [PMID: 22307488 DOI: 10.1177/0884533611433534] [Cited by in Crossref: 116] [Cited by in F6Publishing: 93] [Article Influence: 11.6] [Reference Citation Analysis]
221 Elamin E, Jonkers D, Juuti-Uusitalo K, van Ijzendoorn S, Troost F, Duimel H, Broers J, Verheyen F, Dekker J, Masclee A. Effects of ethanol and acetaldehyde on tight junction integrity: in vitro study in a three dimensional intestinal epithelial cell culture model. PLoS One. 2012;7:e35008. [PMID: 22563376 DOI: 10.1371/journal.pone.0035008] [Cited by in Crossref: 69] [Cited by in F6Publishing: 65] [Article Influence: 6.9] [Reference Citation Analysis]
222 Tetz GV, Ruggles KV, Zhou H, Heguy A, Tsirigos A, Tetz V. Bacteriophages as potential new mammalian pathogens. Sci Rep 2017;7:7043. [PMID: 28765534 DOI: 10.1038/s41598-017-07278-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 35] [Article Influence: 9.0] [Reference Citation Analysis]
223 Patel S, Behara R, Swanson GR, Forsyth CB, Voigt RM, Keshavarzian A. Alcohol and the Intestine. Biomolecules 2015;5:2573-88. [PMID: 26501334 DOI: 10.3390/biom5042573] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 4.9] [Reference Citation Analysis]
224 Larramendi CH. Food allergy diagnosis: are there any missing factors? A theoretical approach. Med Hypotheses 2003;60:731-8. [PMID: 12710912 DOI: 10.1016/s0306-9877(03)00048-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
225 Mendes BG, Schnabl B. From intestinal dysbiosis to alcohol-associated liver disease. Clin Mol Hepatol 2020;26:595-605. [PMID: 32911590 DOI: 10.3350/cmh.2020.0086] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]